After the treatment, the ADAMTS18 gene was expressed in three of the five (60%) ccRCC-derived cell lines; however, it was not expressed in the 786-O or Osr cell lines (Figure 2A). Here, ADAMTS18 is linked to nonpapillary renal cell carcinoma.